HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $24 Price Target
HC Wainwright & Co. analyst Edward White reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $24 price target.
HC Wainwright & Co. Reiterates Buy on Integra Resources, Maintains $4 Price Target
HC Wainwright & Co. analyst Heiko Ihle reiterates Integra Resources (AMEX:ITRG) with a Buy and maintains $4 price target.
Needham Reiterates Buy on Cytokinetics, Maintains $58 Price Target
Needham analyst Serge Belanger reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $58 price target.
Telsey Advisory Group Reiterates Market Perform on Chico’s FAS, Maintains $6 Price Target
Telsey Advisory Group analyst Dana Telsey reiterates Chico's FAS (NYSE:CHS) with a Market Perform and maintains $6 price target.
MKS Instruments Analysts Await Elaboration On Ransomware Impact Post Q4 Results
Benchmark analyst Mark Miller had a Hold rating on MKS Instruments, Inc (NASDAQ:MKSI). For its 4Q22, MKS reported adjusted EPS of $2.00…
Analysts Remain Bullish On SI-BONE, Forecast Q4’s Strength To Continue In 2023
SI-BONE Inc (NASDAQ:SIBN) reported a Q4 EPS loss of $(0.32), beating the consensus of $(0.40) and sales of $31.95 million,…
Big Lots To Have Weak Q4 Results Given Current Consumer Spending Trend, Says Analyst
Telsey Advisory Group analyst Joseph Feldman reiterated a Market Perform rating on the shares of Big Lots Inc (NYSE:BIG) and lowered the…
EverQuote Analyst Remains Bullish As Auto Carrier Spend Rebounds
Needham analyst Mayank Tandon reiterated Buy rating on EverQuote Inc (NASDAQ:EVER) with a $21 price target. EVER reported 4Q22 revenue of $88.3…
Zoom’s Growth Stalls In ‘More Challenging Macro Environment’: What 5 Analysts Say Comes Next After Q4 Earnings
Technology company Zoom Video Communications (NASDAQ: ZM) reported fourth-quarter financial results that came in ahead of Street estimates Monday after the market close.
Guggenheim Reiterates Buy on Seagen, Maintains $170 Price Target
Guggenheim analyst Michael Schmidt reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $170 price target.